Docosahexaenoic Acid on Breath Holding Spells in Children

NCT03965988 ↗

Phase 3 Recruiting 60 enrolled Tanta University

RandomizedParallel-groupQuadruple-blindTreatment

Summary

DHA on Breath Holding Spells

Timeline

Start: 2018-05-01
Primary completion: 2028-11
Completion: 2028-12

Outcome

Met primary endpoint

paper BHS were reported in only 16% of children six months after treatment with piracetam and DHA compared with 50% of those treated with piracetam only PMID 37651975 ↗

paper (P value = 0.001). PMID 37651975 ↗

Publications

Salamah A, Darwish AH. Docosahexaenoic Acid Plus Piracetam Versus Piracetam Alone for Treatment of Breath-Holding Spells in Children: A Randomized Clinical Trial. Pediatr Neurol. 2023 Nov;148:32-36. doi: 10.1016/j.pediatrneurol.2023.08.003. Epub 2023 Aug 9.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	DOCONEXENT	Other / unclassified	—	—